tara

tara
LA Mayor's Office Acknowledges the NDF's Advocacy with GNEM

Saturday, May 3, 2014

Slide and Poster Presentation at the American Academy of Neurology Meeting by Ultragenyx

Ultragenyx, the bio-pharmaceutical company conducting the clinical trial with Sialic Acid -extended release and immediate release has announced positive data from their phase 2 study,  The company presented some of this information prior to this, however the data now seems to have more details.




I hope the graphs and charts I have posted here are legible. Please feel  free to contact me if you have any questions.                                                



No comments: